Your browser doesn't support javascript.
loading
Minimal Efficacy of Nitisinone Treatment in a Novel Mouse Model of Oculocutaneous Albinism, Type 3.
Onojafe, Ighovie F; Megan, Lucyanne H; Melch, Madeline G; Aderemi, Joseph O; Alur, Ramakrishna P; Abu-Asab, Mones S; Chan, Chi-Chao; Bernardini, Isa M; Albert, Jessica S; Cogliati, Tiziana; Adams, David R; Brooks, Brian P.
Afiliação
  • Onojafe IF; Ophthalmic Genetics and Visual Function Branch, National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States.
  • Megan LH; Ophthalmic Genetics and Visual Function Branch, National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States.
  • Melch MG; Ophthalmic Genetics and Visual Function Branch, National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States.
  • Aderemi JO; Ophthalmic Genetics and Visual Function Branch, National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States.
  • Alur RP; Ophthalmic Genetics and Visual Function Branch, National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States.
  • Abu-Asab MS; Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States.
  • Chan CC; Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States.
  • Bernardini IM; Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, United States.
  • Albert JS; Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, United States.
  • Cogliati T; Ophthalmic Genetics and Visual Function Branch, National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States.
  • Adams DR; Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, United States.
  • Brooks BP; Ophthalmic Genetics and Visual Function Branch, National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States.
Invest Ophthalmol Vis Sci ; 59(12): 4945-4952, 2018 10 01.
Article em En | MEDLINE | ID: mdl-30347088
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Albinismo Oculocutâneo / Cicloexanonas / Inibidores Enzimáticos / Nitrobenzoatos Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Invest Ophthalmol Vis Sci Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Albinismo Oculocutâneo / Cicloexanonas / Inibidores Enzimáticos / Nitrobenzoatos Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Invest Ophthalmol Vis Sci Ano de publicação: 2018 Tipo de documento: Article